At a time when many life sciences companies are shrinking their workforce, Vertex Pharmaceuticals Inc. has once again grown its team year-over-year. At a time when many life sciences companies are ...
Hosted on MSN1mon
Vertex gets FDA approval for non-opioid pain relieverShares of Vertex Pharmaceuticals (NASDAQ:VRTX) rose 3% in post-market trading Thursday on news the company had received FDA approval for its non-opioid pain reliever Journavx, also known as ...
Hosted on MSN1mon
Vertex Pharmaceuticals' SWOT analysis: stock poised for growth amid pipeline expansionVertex Pharmaceuticals (NASDAQ:VRTX), a leading biotechnology company with a market capitalization of $113.7 billion, is navigating a critical juncture as it seeks to expand its therapeutic reach ...
The Zacks Consensus Estimate for Vertex’s fourth-quarter 2024 earnings is pegged at 14 cents per share, implying a year-over-year increase of 7.7%. Vertex’s earnings surpassed the Zacks ...
In this article, we are going to take a look at where Vertex, Inc. (NASDAQ:VERX) stands against the other software stocks. Gartner projects that global software spending will rise by 14.2% in 2025 ...
Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback